Company Nunzia Pharmaceutical Corporation Other OTC
Equities
NUNZ
US67097W1027
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 01/09/01 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/19/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | 01/09/01 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/19/05 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,000 | 0 | 0 | 18.04 % |
Stock B | 1 | 434,514,578 | 78,406,578 ( 18.04 %) | 0 |
Company contact information
Nunzia Pharmaceutical Corp.
1627 West 14th Street
90813, Long Beach
+714 609 9117
Sector
1st Jan change | Capi. | |
---|---|---|
+38.51% | 73TCr | |
+33.05% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 20TCr | |
-5.77% | 20TCr | |
+6.19% | 16TCr |